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To establish more directly that the 1,25(OH)2D3 receptor bound to P15, this oligonucleotide was used as a radioactive probe in gel-retardation assays, and the interaction of the shifted bands with monoclonal antibodies against the 1,25(OH)2D3 receptor was examined. Higher-resolution gels revealed that the lower band generated by the osteocalcin 1,25(OH)2D3-response element was, in fact, a doublet and that only the lower of these two bands was 1,25(OH)2D3-receptor-dependent (Fig. 3, osteocalcin) . Migration of the uppermost band (A), as well as the lowest band (B), was retarded by adding XVIE10 (11), a monoclonal antibody against the porcine 1,25(OH)2D3-receptor (antibody 1). Addition of VIIID8C12 and VD2F12, antibodies that interact with the DNA-binding domain of the receptor (11) , decreases the intensity of these bands, presumably by -competing with the DNA probe for 1,25(OH)2D3-receptor binding (antibodies 2 and 3). Addition of a nonspecific antibody of the same species had no effect on the migration of these bands (antibody 4). When P15 was used directly as a ligand for 1,25(OH)2D3-receptor binding, two bands were seen that comigrated with bands A and B of the osteocalcin 1,25(OH)2D3-response element (Fig. 3, hPTH) . Like the complexes generated with the osteocalcin probe, the migration of these two bands was retarded by adding XVIE10. Also, addition ofVIIID8C12 and VD2F12, the antibodies that interact with the DNA-binding domain of the receptor, decreased the intensity of these bands, whereas the nonspecific mouse immunoglobulin had no effect on their intensity or migration.
Analysis of the sequences in the P15 oligonucleotide revealed a motif identical to that repeated in the rat osteopontin 1,25(OH)2D3-response element (AGGTTCA) (7); however, only one copy, on the antisense strand, was present ( (Fig. 4 A and B (5, 8) , human osteocalcin (6), mouse osteopontin (7), and rat calbindin-D9K (9) CACCGCCCAA  TGGGTGTGTG  TATGTGTCTGC  TTTG&ACCTA  TAGTTGAGAT  GTGGCGGGTT  ACCCACACAC  ATACACAGACG  AAACTTGGAT  ATCAACTCTA  P15  TATGTGTCTGC  TTTGAACCTA  TAGTT  ATACACAGACG  AAACTTGGAT  ATCAA  Ml-P15  TATGTtaCTGC  TTTGA&CCTA  TAGTT  ATACAatGACG  AAACTTGGAT  ATCAA  M2-P15  TATGTGTCTGC  TTTGAkaaTA  TAGTT such motif is apparent in the hPTH sequence described. Further investigations will be necessary to determine whether the single motif (AGGTTCA) from the hPTH gene is sufficient for specific interactions with the 1,25(OH)2D3 receptor. It seems unlikely that a single motif can distinguish the 1,25(OH)2D3 receptor from the retinoic acid and thyroid hormone receptors because the spacing between two direct repeats of a similar motif determines the binding specificity of that sequence (15) . The sequences that flank the motif in P15 may, therefore, be critical in its interactions with the 1,25(OH)2D3 receptor. The flanking sequences, as well as the motif itself, are well preserved in both the human (10) and bovine (16) The mechanism of transcriptional repression by steroid hormones is poorly understood. It is possible that steroid receptors mediate their down-regulatory effects by binding to consensus sequences that differ from those responsible for up-regulation. Binding of steroid receptors to these negative response elements may cause distinctive conformational changes, thereby repressing transcription instead of activating it. Sequences in the preopiomelanocortin gene that mediate down-regulation in response to dexamethasone, for example, bind the glucocorticoid receptor but do not contain a classic glucocorticoid-response element (17) . Mutation of these sequences results in a parallel loss of receptor binding and of transcriptional repression, suggesting that they contain a "negative glucocorticoid-response element." The sequences in the hPTH gene that confer down-regulation do differ from the up-regulatory 1,25(OH)2D3-response elements in that only a single motif is present. If the sequences flanking this motif contain bases necessary for receptor binding, the sequences in P15 may represent a "negative 1,25(OH)2D3-response element." However, because down-regulation is not seen in the ROS 17/2.8 cells, cellular factors other than (18) (19) (20) determine whether the same glucocorticoid-response element mediates activation or repression: in cells containing both c-fos and c-jun, repression in response to dexamethasone is observed, whereas, in relative c-jun excess, activation is seen (18) . Cell-specific transcriptional repression by steroid receptors may also be caused by interference with the binding and/or action of positive transcription factors. This interference is thought to be the mechanism by which the glucocorticoid receptor mediates transcriptional down-regulation of the gene encoding the human glycoprotein a subunit. The glucocorticoid receptor is thought to interact with a proximal region of this gene that contains a tissue-specific enhancer and two functional cAMP-response elements. The receptor has been shown to bind these DNA sequences (21) ; however, the inhibition of transcription may depend on interactions of the receptor with other transcription factors, rather than on its DNA binding (22) .
An accessory factor is thought necessary for high-affinity interactions of the 1,25(OH)2D3 receptor with its upregulatory-response elements (23) (24) (25) . Recent characterization of the retinoid X receptor has demonstrated that this protein increases the affinity ofthe retinoic acid receptor, the thyroid receptor, and the 1,25(OH)2D3 receptor for their respective response elements (26, 27) . However, the transcriptional consequences of the retinoid X receptor-1,25(OH)2D3 receptor interactions are modest (26) . Other accessory factors may, therefore, be required for interactions of the 1,25(OH)2D3 receptor with its response element. In the context of particular DNA sequences, different accessory factors may interact with the receptor and determine the transcriptional consequences of receptor binding.
The observation of down-regulation by these hPTH sequences in GH4C1 cells raises interesting questions regarding the cell-specificity of factors required for down-regulation in response to 1,25(OH)2D3. This down-regulation suggests that the GH4C1 cell and the parathyroid cell may contain related cell-specific transcription factors not expressed in ROS 17/ 2.8 cells. The best-characterized pituitary transcription factor, Pit-i, is a member of the POU family of homeodomain proteins (28) . Examining the sequences in P15 reveals a poorly conserved Pit-1 consensus sequence [A(T/A)(T/ A)TATNCAT] on both the sense (6/10 conserved bases) and antisense (7/10 conserved bases) strands. A POU family member, or unrelated cell-specific transcription factor may be a critical determinant of 1,25(OH)2D3-induced PTH gene down-regulation in the parathyroid gland. Further analysis of the binding and functional properties of mutant P15 oligonucleotides should clarify how cellular factors interact with the 1,25(OH)2D3 receptor to mediate down-regulation of hPTH gene transcription.
